[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-ge-healthcare-stock-beats-q4-estimates-as-record-backlog-hits-21-8-billion-EN":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":258,"relatedPosts":264,"suggestedPosts":339},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":238,"editor":244,"categories":249,"relatedPosts":255,"seo":256},102299,"GE HealthCare Stock Beats Q4 Estimates as Record Backlog Hits $21.8 Billion","2026-04-21T13:00:00","2026-04-21T00:55:09","\u003Cp>Nine major product launches, a $21.8B backlog, and 36% model upside. GE HealthCare stock is pricing in a trough. Is that right?\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-key-stats-ge-healthcare-technologies-q4-2025-earnings\">\u003Cstrong>Key Stats — GE HealthCare Technologies Q4 2025 Earnings\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Current price:\u003C\u002Fstrong> ~$74\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Q4 2025 revenue:\u003C\u002Fstrong> $5.7B (+7% YoY reported; +5% organic)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Q4 2025 adjusted EPS:\u003C\u002Fstrong> $1.44 (-0.7% YoY; +11% ex-tariffs)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>FY2025 revenue:\u003C\u002Fstrong> $20.6B (+3.5% organic)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>FY2025 adjusted EPS:\u003C\u002Fstrong> $4.59 (+2%; +12% ex-tariffs)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>FY2026 organic revenue guidance:\u003C\u002Fstrong> +3% to +4%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>FY2026 adjusted EPS guidance:\u003C\u002Fstrong> $4.95–$5.15 (+8% to +12%)\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>TIKR model price target:\u003C\u002Fstrong> $100.85\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Implied upside:\u003C\u002Fstrong> ~36% over ~5 years (around 7% annualized)\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>GE HealthCare stock trades at a 36% discount to TIKR’s model price target. See the full valuation breakdown, for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-ge-healthcare-stock-beats-q4-estimates-raises-2026-eps-guide-to-4-95-5-15\">GE HealthCare Stock Beats Q4 Estimates, Raises 2026 EPS Guide to $4.95–$5.15\u003C\u002Fh2>\n\n\n\n\u003Cp>GE HealthCare stock delivered Q4 2025 revenue of $5.7B, up 7.1% on a reported basis and 4.8% organically, exceeding internal expectations.\u003C\u002Fp>\n\n\n\n\u003Cp>Adjusted EPS came in at $1.44 for the quarter, down 0.7% year-over-year but up 11% excluding approximately $0.17 per share in tariff impact.\u003C\u002Fp>\n\n\n\n\u003Cp>Pharmaceutical Diagnostics was the standout segment, posting Q4 organic revenue growth of 12.7%, driven by global contrast media demand, pricing execution, and adoption of the company’s U.S. radiopharmaceutical MPI portfolio.\u003C\u002Fp>\n\n\n\n\u003Cp>Imaging delivered Q4 organic growth of 5.3%, supported by strong execution in EMEA and nuclear medicine, while Advanced Visualization Solutions grew 4.2% organically with continued momentum in cardiovascular ultrasound.\u003C\u002Fp>\n\n\n\n\u003Cp>Patient Care Solutions was the drag on the quarter, with organic revenue declining 1.1% year-over-year due to weakness in Life Support Solutions, though EBIT margin recovered 530 basis points sequentially following the resolution of a prior-period product hold.\u003C\u002Fp>\n\n\n\n\u003Cp>GE HealthCare stock exited the quarter with a record backlog of $21.8B, up $2B year-over-year and $600M sequentially, with a book-to-bill ratio of 1.06x.\u003C\u002Fp>\n\n\n\n\u003Cp>According to CFO Jay Saccaro on the Q4 2025 earnings call, FY2025 tariff impact totaled approximately $245M to EBIT and $0.43 to adjusted EPS; excluding those headwinds, adjusted EBIT margin would have expanded 20 basis points and adjusted EPS would have grown 12%.\u003C\u002Fp>\n\n\n\n\u003Cp>For FY2026, management guided organic revenue growth of 3%–4%, adjusted EPS of $4.95–$5.15, and free cash flow of approximately $1.7B, representing 13% growth year-over-year.\u003C\u002Fp>\n\n\n\n\u003Cp>The company repurchased $200M in shares at an average price of about $71 since its board-authorized buyback program began in April 2025.\u003C\u002Fp>\n\n\n\n\u003Cp id=\"h-what-happened\">Management flagged a cautious outlook on China as a deliberate headwind baked into the guidance, while citing strong order pipelines in the U.S. and EMEA as the primary supports for the 2026 revenue outlook.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>GE HealthCare just beat Q4 and raised 2026 guidance. Check whether the stock is still priced for a trough on TIKR, for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-ge-healthcare-stock-financials-tariffs-compress-margins-recovery-path-points-to-2027\">GE HealthCare Stock Financials: Tariffs Compress Margins, Recovery Path Points to 2027\u003C\u002Fh2>\n\n\n\n\u003Cp>GE HealthCare stock’s Q4 income statement tells a story of solid volume growth running into a tariff wall that has pushed margins well below where they should be for a business with this backlog.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"678\" data-public-id=\"images\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_678,c_scale\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA\" alt=\"ge healthcare stock financials\" class=\"wp-post-102299 wp-image-102303\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1776732823\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_678,c_scale\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_508,c_scale\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_794,c_scale\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1776732823\u002Fimages\u002Fimage-588_1023035f984\u002Fimage-588_1023035f984.png?_i=AA 1266w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">GEHC Stock Financials\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ffinancials?cid=1804385326&tid=1816998317&tab=is&ref=q2enxr\"> \u003Cstrong>(TIKR)\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Gross margin came in at ~40% in Q4 2025, down from ~43% in Q4 2024, as tariff costs and mix weighed on the cost structure despite improved volume and pricing execution.\u003C\u002Fp>\n\n\n\n\u003Cp>Operating income was $0.83B, with an operating margin of 14.5%, compared to 17% in Q4 2024, a 250-basis-point decline year-over-year.\u003C\u002Fp>\n\n\n\n\u003Cp>The trend across 2025 shows operating margin compressing each quarter from ~15% in Q1 to 14.5% in Q4, a meaningful step back from the 17% level the business was running at a year earlier.\u003C\u002Fp>\n\n\n\n\u003Cp id=\"h-wall-street-s-take-on-x-stock\">Management guided FY2026 adjusted EBIT margin of 15.8%–16.1%, representing 50–80 basis points of expansion from the 15.3% full-year 2025 figure, with tariff mitigation work and Heartbeat-driven productivity gains cited as the primary drivers.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Is GE HealthCare Stock Undervalued? What the TIKR Model Shows\u003C\u002Fh2>\n\n\n\n\u003Cp>The TIKR model prices GE HealthCare stock at a target of $100.85, implying ~36% total return over 4.7 years from the current price near $74, or about 6.8% annualized.\u003C\u002Fp>\n\n\n\n\u003Cp>The mid-case assumptions are a revenue CAGR of 3.6%, a net income margin of 11.6%, and EPS CAGR of 5.1%, reflecting a business in the early stages of a product-cycle-driven reacceleration.\u003C\u002Fp>\n\n\n\n\u003Cp>The Q4 report reinforces the setup: record backlog, raised EPS guidance, and a tariff burden that is declining rather than growing in 2026 all support the forward earnings path the model is built on.\u003C\u002Fp>\n\n\n\n\u003Cp>GE HealthCare stock is priced for a company still working through a tariff-depressed trough, not for what the innovation pipeline unlocks in 2027 and 2028.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA\" alt=\"ge healthcare stock valuation model results\" class=\"wp-post-102299 wp-image-102301\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1776732334\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1776732334\u002Fimages\u002FGEHC_valuation_model-2_102301d5746\u002FGEHC_valuation_model-2_102301d5746.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">GEHC Stock Valuation Model Results \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>(TIKR)\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>The central tension for GE HealthCare stock: the investment case hinges on whether 9 major product launches convert from order pipeline to revenue at scale in 2027, or whether China pressure, tariff uncertainty, and slower-than-expected Flyrcado ramp prevent the margin step-up the model requires.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Thesis Intact\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Record backlog of $21.8B (up $2B YoY) provides multiyear revenue visibility independent of near-term order fluctuations, with Q4 book-to-bill of 1.06x and trailing 12-month orders growth in the mid-single digits\u003C\u002Fli>\n\n\n\n\u003Cli>Tariff headwind is shrinking: FY2025 impact was ~$245M to EBIT; management guided 2026 tariff expense below that level, with Heartbeat-driven supply chain shifts already repositioning PET\u002FCT and surgery lines to more tariff-efficient geographies\u003C\u002Fli>\n\n\n\n\u003Cli>Pharmaceutical Diagnostics continues to outperform with 12.7% Q4 organic growth, and Flyrcado dose delivery reached ~220 weekly doses as of January 23, with management reaffirming $500M+ revenue potential by end-2028\u003C\u002Fli>\n\n\n\n\u003Cli>FY2026 adjusted EPS guidance of $4.95–$5.15 implies 8%–12% growth, with about $0.30 from volume growth and $0.30 from cost and productivity initiatives even before the new product revenue wave\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>Thesis at Risk\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Operating margin has compressed from 17.0% in Q4 2024 to 14.5% in Q4 2025, and the FY2026 adjusted EBIT guide of 15.8%–16.1% still sits well below the company’s medium-term target range of high teens to 20%-plus\u003C\u002Fli>\n\n\n\n\u003Cli>China, approximately 10% of total sales, is budgeted down in 2026 after a Q4 2025 that management described as the most challenging comparison quarter of the year; VBP tender win improvements have not yet translated into order flow\u003C\u002Fli>\n\n\n\n\u003Cli>Photon-counting CT (Photonova) and total body PET are not expected to contribute meaningfully to revenue until 2027, meaning the 2026 guide carries limited innovation upside relative to the product launches investors are underwriting\u003C\u002Fli>\n\n\n\n\u003Cli>Amneal has begun launching generic codes of iohexol, the core Omnipaque contrast agent product; while management expressed confidence in supply consistency and portfolio breadth as differentiators, the entry introduces pricing pressure into the highest-growth segment\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Nine product launches are loading for 2027. TIKR’s valuation model shows what that innovation cycle is worth at today’s price, for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-ge-healthcare-technologies-inc\">\u003Cstrong>Should You Invest in GE HealthCare Technologies Inc.?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.\u003C\u002Fp>\n\n\n\n\u003Cp>Pull up GEHC stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.\u003C\u002Fp>\n\n\n\n\u003Cp>You can build a free watchlist to track GE HealthCare Technologies Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Access Professional Tools to Analyze GEHC stock on TIKR for Free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",1180,"en","\u002Fblog\u002Fge-healthcare-stock-beats-q4-estimates-as-record-backlog-hits-21-8-billion","ge-healthcare-stock-beats-q4-estimates-as-record-backlog-hits-21-8-billion","images\u002FFEATURED-IMAGE-MAKER-366_1023023c67e\u002FFEATURED-IMAGE-MAKER-366_1023023c67e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776732671\u002Fimages\u002FFEATURED-IMAGE-MAKER-366_1023023c67e\u002FFEATURED-IMAGE-MAKER-366_1023023c67e.png?_i=AA",{"altText":225,"imageCredit":237},"TIKR",{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":243},"Gian Estrada","giantikr","author","",[],{"name":245,"slug":246,"role":247,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":248},"David Hanson","davidtikr","editor",[],[250],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},"Earnings Updates","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",0,[],{"title":225,"metaDesc":257,"opengraphDescription":257,"twitterTitle":225,"twitterDescription":257},"Nine major product launches, a $21.8B backlog, and 36% model upside. GE HealthCare stock is pricing in a trough. Is that right?",{"title":225,"description":257,"twitterTitle":225,"twitterDescription":257,"author":239,"articlePublisher":259,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":260,"twitterData1":261,"ogTitle":225,"ogDescription":257,"ogUrl":232,"ogImage":235,"ogImageWidth":262,"ogImageHeight":263,"ogImageSecureUrl":235,"ogImageAlt":225,"twitterImage":235},"TIKR.com","Est. reading time","7 minutes",1200,630,[265,280,294,309,324],{"id":254,"title":266,"date":267,"excerpt":268,"wordCount":269,"uri":270,"slug":271,"cloudinaryAssetId":272,"featuredImageOriginalUrl":273,"featuredImageMetadata":274,"author":275,"categories":277,"relatedPosts":279},"Raymond James Financial Stock Holds 20% Margin Target as Capital Markets Revenue Falls to $380M","2026-04-21 13:00:00","Raymond James held its 20% margin target in Q1, but Capital Markets fell hard. The question is whether the pipeline turns into revenue.",1318,"\u002Fblog\u002Fraymond-james-financial-stock-holds-20-margin-target-as-capital-markets-revenue-falls-to-380m","raymond-james-financial-stock-holds-20-margin-target-as-capital-markets-revenue-falls-to-380m","images\u002FFEATURED-IMAGE-MAKER-363_1022597fe1a\u002FFEATURED-IMAGE-MAKER-363_1022597fe1a","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776675649\u002Fimages\u002FFEATURED-IMAGE-MAKER-363_1022597fe1a\u002FFEATURED-IMAGE-MAKER-363_1022597fe1a.png?_i=AA",{"altText":266},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":276},[],[278],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},[],{"id":254,"title":281,"date":267,"excerpt":282,"wordCount":283,"uri":284,"slug":285,"cloudinaryAssetId":286,"featuredImageOriginalUrl":287,"featuredImageMetadata":288,"author":289,"categories":291,"relatedPosts":293},"Deere Stock Beats Q1 as Construction Orders Hit Highest Level Since 2024","Deere's Q1 was better than expected. The TIKR model shows ~28% upside from here. But one segment's margins are still under serious pressure.",1189,"\u002Fblog\u002Fdeere-stock-beats-q1-as-construction-orders-hit-highest-level-since-2024","deere-stock-beats-q1-as-construction-orders-hit-highest-level-since-2024","images\u002FFEATURED-IMAGE-MAKER-365_1022989aeac\u002FFEATURED-IMAGE-MAKER-365_1022989aeac","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776729446\u002Fimages\u002FFEATURED-IMAGE-MAKER-365_1022989aeac\u002FFEATURED-IMAGE-MAKER-365_1022989aeac.png?_i=AA",{"altText":281},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":290},[],[292],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},[],{"id":254,"title":295,"date":296,"excerpt":297,"wordCount":298,"uri":299,"slug":300,"cloudinaryAssetId":301,"featuredImageOriginalUrl":302,"featuredImageMetadata":303,"author":304,"categories":306,"relatedPosts":308},"Zillow Group Stock Hits Full-Year GAAP Profitability as Rentals Accelerates","2026-04-20 19:40:00","Zillow hit GAAP profitability and guided $700M for Q1 2026. The question is how much of the thesis needs housing to recover.",1262,"\u002Fblog\u002Fzillow-group-stock-hits-full-year-gaap-profitability-as-rentals-accelerates","zillow-group-stock-hits-full-year-gaap-profitability-as-rentals-accelerates","images\u002FFEATURED-IMAGE-MAKER-356_1022025f673\u002FFEATURED-IMAGE-MAKER-356_1022025f673","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776661880\u002Fimages\u002FFEATURED-IMAGE-MAKER-356_1022025f673\u002FFEATURED-IMAGE-MAKER-356_1022025f673.png?_i=AA",{"altText":295},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":305},[],[307],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},[],{"id":254,"title":310,"date":311,"excerpt":312,"wordCount":313,"uri":314,"slug":315,"cloudinaryAssetId":316,"featuredImageOriginalUrl":317,"featuredImageMetadata":318,"author":319,"categories":321,"relatedPosts":323},"CBRE Group Posts Record Q4 Revenue and Core EPS in Strong 2025 Finish","2026-04-20 19:20:00","CBRE posted record Q4 revenue and 18% EPS growth, but the real debate is whether data center momentum holds into 2026.",1190,"\u002Fblog\u002Fcbre-group-posts-record-q4-revenue-and-core-eps-in-strong-2025-finish","cbre-group-posts-record-q4-revenue-and-core-eps-in-strong-2025-finish","images\u002FFEATURED-IMAGE-MAKER-355_1021947a26b\u002FFEATURED-IMAGE-MAKER-355_1021947a26b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776660491\u002Fimages\u002FFEATURED-IMAGE-MAKER-355_1021947a26b\u002FFEATURED-IMAGE-MAKER-355_1021947a26b.png?_i=AA",{"altText":310},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":320},[],[322],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},[],{"id":254,"title":325,"date":326,"excerpt":327,"wordCount":328,"uri":329,"slug":330,"cloudinaryAssetId":331,"featuredImageOriginalUrl":332,"featuredImageMetadata":333,"author":334,"categories":336,"relatedPosts":338},"Astera Labs Revenue More Than Doubled in 2025. Is the Stock Still Cheap?","2026-04-20 19:00:00","Astera Labs more than doubled revenue in 2025. But with opex accelerating and the biggest product ramp still ahead, the debate is just beginning.",1254,"\u002Fblog\u002Fastera-labs-revenue-more-than-doubled-in-2025-is-the-stock-still-cheap","astera-labs-revenue-more-than-doubled-in-2025-is-the-stock-still-cheap","images\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776656657\u002Fimages\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed.png?_i=AA",{"altText":325},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":335},[],[337],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},[],[340,360,375,390,405,420,437,451,466,480,494,513,528,543],{"id":254,"title":341,"date":342,"excerpt":343,"wordCount":344,"uri":345,"slug":346,"cloudinaryAssetId":347,"featuredImageOriginalUrl":348,"featuredImageMetadata":349,"author":350,"categories":354,"relatedPosts":359},"UPS Stock Has Lost 39% in 5 Years. With Q1 Earnings Days Away, Is Now the Time to Buy?","2026-04-21 12:50:00","UPS is days away from its most consequential earnings report in years, still trading near multi-year lows after losing 39% over five years. The Amazon glide-down is weeks from completion, a nationwide RFID rollout just launched, and CEO Carol Tomé has called June 2026 the inflection point. April 28 is the first hard test of whether she's right.",1357,"\u002Fblog\u002Fups-stock-has-lost-39-in-5-years-with-q1-earnings-days-away-is-now-the-time-to-buy","ups-stock-has-lost-39-in-5-years-with-q1-earnings-days-away-is-now-the-time-to-buy","images\u002F7-4_1023163cde6\u002F7-4_1023163cde6","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776737005\u002Fimages\u002F7-4_1023163cde6\u002F7-4_1023163cde6.png?_i=AA",{"altText":341},{"name":351,"slug":352,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":353},"Wiltone Asuncion","wiltonetikr",[],[355],{"name":356,"slug":357,"uri":358,"description":242,"postsCount":254},"General Investing","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":254,"title":361,"date":362,"excerpt":363,"wordCount":364,"uri":365,"slug":366,"cloudinaryAssetId":367,"featuredImageOriginalUrl":368,"featuredImageMetadata":369,"author":370,"categories":372,"relatedPosts":374},"ExxonMobil Has Pulled Back 16% From Its All-Time High. Is It Finally a Buy?","2026-04-21 12:40:00","ExxonMobil hit an all-time high of $176.41 in late March as the Strait of Hormuz crisis sent crude surging. A brief ceasefire announcement then sent oil plunging more than 9%, pulling XOM down to $147.68. Here's whether the pullback is a buying opportunity or a warning sign. \n",1348,"\u002Fblog\u002Fexxonmobil-has-pulled-back-16-from-its-all-time-high-is-it-finally-a-buy","exxonmobil-has-pulled-back-16-from-its-all-time-high-is-it-finally-a-buy","images\u002F6-4_1023150168a\u002F6-4_1023150168a","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736994\u002Fimages\u002F6-4_1023150168a\u002F6-4_1023150168a.png?_i=AA",{"altText":361},{"name":351,"slug":352,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":371},[],[373],{"name":356,"slug":357,"uri":358,"description":242,"postsCount":254},[],{"id":254,"title":376,"date":377,"excerpt":378,"wordCount":379,"uri":380,"slug":381,"cloudinaryAssetId":382,"featuredImageOriginalUrl":383,"featuredImageMetadata":384,"author":385,"categories":387,"relatedPosts":389},"Tim Cook Is Stepping Down as Apple CEO. Here's Why the Stock Still Has Upside in 2026","2026-04-21 12:30:00","Apple just confirmed one of the most consequential leadership changes in corporate history: Tim Cook is stepping down as CEO. For investors sitting at $273, the real question is whether the transition is a reason to buy, hold, or worry. ",1267,"\u002Fblog\u002Ftim-cook-is-stepping-down-as-apple-ceo-heres-why-the-stock-still-has-upside-in-2026","tim-cook-is-stepping-down-as-apple-ceo-heres-why-the-stock-still-has-upside-in-2026","images\u002F5-4_1023140116e\u002F5-4_1023140116e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736983\u002Fimages\u002F5-4_1023140116e\u002F5-4_1023140116e.png?_i=AA",{"altText":376},{"name":351,"slug":352,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":386},[],[388],{"name":356,"slug":357,"uri":358,"description":242,"postsCount":254},[],{"id":254,"title":391,"date":392,"excerpt":393,"wordCount":394,"uri":395,"slug":396,"cloudinaryAssetId":397,"featuredImageOriginalUrl":398,"featuredImageMetadata":399,"author":400,"categories":402,"relatedPosts":404},"JPMorgan Stock Falls After Q1 2026 Earnings Beat: What a $338 Street Target Means for Investors","2026-04-21 12:20:00","JPMorgan posted record trading revenue and beat Q1 2026 earnings estimates, yet the stock fell on a net interest income guidance cut. Jamie Dimon warned the next credit cycle could be worse than investors expect. Here's what the numbers say. ",1105,"\u002Fblog\u002Fjpmorgan-stock-falls-after-q1-2026-earnings-beat-what-a-338-street-target-means-for-investors","jpmorgan-stock-falls-after-q1-2026-earnings-beat-what-a-338-street-target-means-for-investors","images\u002F4-4_10231354c69\u002F4-4_10231354c69","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736975\u002Fimages\u002F4-4_10231354c69\u002F4-4_10231354c69.png?_i=AA",{"altText":391},{"name":351,"slug":352,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":401},[],[403],{"name":356,"slug":357,"uri":358,"description":242,"postsCount":254},[],{"id":254,"title":406,"date":407,"excerpt":408,"wordCount":409,"uri":410,"slug":411,"cloudinaryAssetId":412,"featuredImageOriginalUrl":413,"featuredImageMetadata":414,"author":415,"categories":417,"relatedPosts":419},"NVIDIA Stock Is Up 18% in 10 Days. Is the Six-Month Consolidation Finally Over?","2026-04-21 12:10:00","NVIDIA stock has broken out of a six-month trading range, surging 18% in 10 days to reclaim $200 for the first time since its October all-time high. Investors are asking whether this is finally the real move. Here's what the data says.",1374,"\u002Fblog\u002Fnvidia-stock-is-up-18-in-10-days-is-the-six-month-consolidation-finally-over","nvidia-stock-is-up-18-in-10-days-is-the-six-month-consolidation-finally-over","images\u002F3-4_10231249633\u002F3-4_10231249633","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736971\u002Fimages\u002F3-4_10231249633\u002F3-4_10231249633.png?_i=AA",{"altText":406},{"name":351,"slug":352,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":416},[],[418],{"name":356,"slug":357,"uri":358,"description":242,"postsCount":254},[],{"id":254,"title":421,"date":342,"excerpt":422,"wordCount":423,"uri":424,"slug":425,"cloudinaryAssetId":426,"featuredImageOriginalUrl":427,"featuredImageMetadata":428,"author":429,"categories":431,"relatedPosts":436},"Honeywell Stock Is at a Trough Multiple Ahead of Its Biggest Decade Re-Rating","A record $37 billion backlog and a Pentagon defense deal push HON stock toward a $322 mid-case target ahead of the Aerospace spin.\n",1709,"\u002Fblog\u002Fhoneywell-stock-is-at-a-trough-multiple-ahead-of-its-biggest-decade-re-rating","honeywell-stock-is-at-a-trough-multiple-ahead-of-its-biggest-decade-re-rating","images\u002FFEATURED-IMAGE-MAKER-362_10225401718\u002FFEATURED-IMAGE-MAKER-362_10225401718","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776673740\u002Fimages\u002FFEATURED-IMAGE-MAKER-362_10225401718\u002FFEATURED-IMAGE-MAKER-362_10225401718.png?_i=AA",{"altText":421},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":430},[],[432],{"name":433,"slug":434,"uri":435,"description":242,"postsCount":254},"Stock Reviews","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":254,"title":438,"date":362,"excerpt":439,"wordCount":440,"uri":441,"slug":442,"cloudinaryAssetId":443,"featuredImageOriginalUrl":444,"featuredImageMetadata":445,"author":446,"categories":448,"relatedPosts":450},"Humana Stock Could Return 250% if the Medicare Advantage Recovery Delivers","CMS finalized a 5% Medicare payment boost. Now Humana faces Q1 earnings on April 29, and the benefit ratio tells the whole story.",1472,"\u002Fblog\u002Fhumana-stock-could-return-250-if-the-medicare-advantage-recovery-delivers","humana-stock-could-return-250-if-the-medicare-advantage-recovery-delivers","images\u002FFEATURED-IMAGE-MAKER-360_102231b06f7\u002FFEATURED-IMAGE-MAKER-360_102231b06f7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776666014\u002Fimages\u002FFEATURED-IMAGE-MAKER-360_102231b06f7\u002FFEATURED-IMAGE-MAKER-360_102231b06f7.png?_i=AA",{"altText":438},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":447},[],[449],{"name":433,"slug":434,"uri":435,"description":242,"postsCount":254},[],{"id":254,"title":452,"date":362,"excerpt":453,"wordCount":454,"uri":455,"slug":456,"cloudinaryAssetId":457,"featuredImageOriginalUrl":458,"featuredImageMetadata":459,"author":461,"categories":463,"relatedPosts":465},"Novo Deal, Eucalyptus Acquisition, FDA Peptides: Three Catalysts Reshaping Hims & Hers in 2026","The Novo deal ended the legal risk. The Eucalyptus acquisition opens Australia and Japan. The real question is whether Q1 earnings confirm the pivot.\n",1407,"\u002Fblog\u002Fnovo-deal-eucalyptus-acquisition-fda-peptides-three-catalysts-reshaping-hims-hers-in-2026","novo-deal-eucalyptus-acquisition-fda-peptides-three-catalysts-reshaping-hims-hers-in-2026","images\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776672879\u002Fimages\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed.png?_i=AA",{"altText":460},"Novo Deal, Eucalyptus Acquisition, FDA Peptides: Three Catalysts Reshaping Hims & Hers in 2026",{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":462},[],[464],{"name":433,"slug":434,"uri":435,"description":242,"postsCount":254},[],{"id":254,"title":467,"date":377,"excerpt":468,"wordCount":469,"uri":470,"slug":471,"cloudinaryAssetId":472,"featuredImageOriginalUrl":473,"featuredImageMetadata":474,"author":475,"categories":477,"relatedPosts":479},"From $145 to $244 in a Year: Can Marathon Petroleum Stock Sustain Its Refining Advantage?","Marathon Petroleum trades at 10x forward earnings on a year when EPS is expected to nearly double. Something doesn't add up.",1578,"\u002Fblog\u002Ffrom-145-to-244-in-a-year-can-marathon-petroleum-stock-sustain-its-refining-advantage","from-145-to-244-in-a-year-can-marathon-petroleum-stock-sustain-its-refining-advantage","images\u002FFEATURED-IMAGE-MAKER-358_102214df16b\u002FFEATURED-IMAGE-MAKER-358_102214df16b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776663396\u002Fimages\u002FFEATURED-IMAGE-MAKER-358_102214df16b\u002FFEATURED-IMAGE-MAKER-358_102214df16b.png?_i=AA",{"altText":467},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":476},[],[478],{"name":433,"slug":434,"uri":435,"description":242,"postsCount":254},[],{"id":254,"title":481,"date":377,"excerpt":482,"wordCount":483,"uri":484,"slug":485,"cloudinaryAssetId":486,"featuredImageOriginalUrl":487,"featuredImageMetadata":488,"author":489,"categories":491,"relatedPosts":493},"Merck Spends $6.7 Billion on a CML Drug: What the Terns Deal Means for MRK Investors in 2026","Merck spent $6.7 billion on a CML drug with multibillion-dollar potential. The April 30 call reveals if the core business is tracking.",1340,"\u002Fblog\u002Fmerck-spends-6-7-billion-on-a-cml-drug-what-the-terns-deal-means-for-mrk-investors-in-2026","merck-spends-6-7-billion-on-a-cml-drug-what-the-terns-deal-means-for-mrk-investors-in-2026","images\u002FFEATURED-IMAGE-MAKER-359_1022224415d\u002FFEATURED-IMAGE-MAKER-359_1022224415d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776664726\u002Fimages\u002FFEATURED-IMAGE-MAKER-359_1022224415d\u002FFEATURED-IMAGE-MAKER-359_1022224415d.png?_i=AA",{"altText":481},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":490},[],[492],{"name":433,"slug":434,"uri":435,"description":242,"postsCount":254},[],{"id":254,"title":495,"date":496,"excerpt":242,"wordCount":497,"uri":498,"slug":499,"cloudinaryAssetId":500,"featuredImageOriginalUrl":501,"featuredImageMetadata":502,"author":503,"categories":507,"relatedPosts":512},"Jeffrey Gendell: From a 91.5% Drawdown to a 100-Bagger","2026-04-21 12:01:34",521,"\u002Fblog\u002Fjeffrey-gendell","jeffrey-gendell","images\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776772825\u002Fimages\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return.png?_i=AA",{"altText":495},{"name":504,"slug":505,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":506},"Sahil Khetpal","sahil",[],[508],{"name":509,"slug":510,"uri":511,"description":242,"postsCount":254},"Top Investors","top-investors","\u002Fblog\u002Fcategory\u002Ftop-investors",[],{"id":254,"title":514,"date":515,"excerpt":516,"wordCount":328,"uri":517,"slug":518,"cloudinaryAssetId":519,"featuredImageOriginalUrl":520,"featuredImageMetadata":521,"author":522,"categories":524,"relatedPosts":527},"Block Raises 2026 AOI Guidance to $3.2 Billion After Strongest NVA Year on Record","2026-04-20 16:00:00","Block raised its 2026 AOI guide to $3.2 billion, up 54%. Nearly 60% of that number is riding on the second half.","\u002Fblog\u002Fblock-raises-2026-aoi-guidance-to-3-2-billion-after-strongest-nva-year-on-record","block-raises-2026-aoi-guidance-to-3-2-billion-after-strongest-nva-year-on-record","images\u002FFEATURED-IMAGE-MAKER-342_102031506a3\u002FFEATURED-IMAGE-MAKER-342_102031506a3","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776522160\u002Fimages\u002FFEATURED-IMAGE-MAKER-342_102031506a3\u002FFEATURED-IMAGE-MAKER-342_102031506a3.png?_i=AA",{"altText":514},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":523},[],[525],{"name":76,"slug":75,"uri":526,"description":242,"postsCount":254},"\u002Fblog\u002Fcategory\u002Ffundamental-analysis",[],{"id":254,"title":529,"date":530,"excerpt":531,"wordCount":532,"uri":533,"slug":534,"cloudinaryAssetId":535,"featuredImageOriginalUrl":536,"featuredImageMetadata":537,"author":538,"categories":540,"relatedPosts":542},"Amer Sports Stock Delivers 27% Revenue Growth as Salomon Crosses $2 Billion in Sales","2026-04-19 12:40:00","Amer Sports grew 27% in 2025 with three brand engines firing. The question is whether the margin investment in Salomon is temporary or structural.",1247,"\u002Fblog\u002Famer-sports-stock-delivers-27-revenue-growth-as-salomon-crosses-2-billion-in-sales","amer-sports-stock-delivers-27-revenue-growth-as-salomon-crosses-2-billion-in-sales","images\u002FFEATURED-IMAGE-MAKER-347_102065dfae9\u002FFEATURED-IMAGE-MAKER-347_102065dfae9","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776566743\u002Fimages\u002FFEATURED-IMAGE-MAKER-347_102065dfae9\u002FFEATURED-IMAGE-MAKER-347_102065dfae9.png?_i=AA",{"altText":529},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":539},[],[541],{"name":76,"slug":75,"uri":526,"description":242,"postsCount":254},[],{"id":254,"title":544,"date":545,"excerpt":546,"wordCount":547,"uri":548,"slug":549,"cloudinaryAssetId":550,"featuredImageOriginalUrl":551,"featuredImageMetadata":552,"author":553,"categories":555,"relatedPosts":557},"Helios Technologies Q4 2025: EPS Up 145%, Dividend Raised for the First Time Ever","2026-04-18 15:00:00","Helios Technologies returned to revenue growth for the first time in three years. Whether the momentum holds through 2026 is a harder question.",1307,"\u002Fblog\u002Fhelios-technologies-q4-2025-eps-up-145-dividend-raised-for-the-first-time-ever","helios-technologies-q4-2025-eps-up-145-dividend-raised-for-the-first-time-ever","images\u002FFEATURED-IMAGE-MAKER-341_101995d387e\u002FFEATURED-IMAGE-MAKER-341_101995d387e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776497160\u002Fimages\u002FFEATURED-IMAGE-MAKER-341_101995d387e\u002FFEATURED-IMAGE-MAKER-341_101995d387e.png?_i=AA",{"altText":544},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":554},[],[556],{"name":76,"slug":75,"uri":526,"description":242,"postsCount":254},[]]